Pharmaceuticals in the Netherlands
Summary
Pharmaceuticals in the Netherlands industry profile provides topline qualitative and quantitative summary information including: market share, market size value 201317, and forecast to 2022. The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Synopsis
Essential resource for topline data and analysis covering the Netherlands pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Key highlights
The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
The Dutch pharmaceuticals market had total revenues of $5.1bn in 2017, representing a compound annual rate of change CARC of 2.7% between 2013 and 2017.
The Ministry of Health, Welfare and Sport sets maximum allowable prices for medicines in accordance with the Medicine Prices Act. When buying in drugs, pharmacists may not pay more than the maximum prices.
Generics substitution at the pharmacy level and prescribing drugs by their International Nonproprietary Name INN are allowed and indeed actively encouraged in the Netherlands. These cost saving measures disrupts the ability of the market to produce growth.
Scope
Save time carrying out entrylevel research by identifying the size, growth, and leading players in the pharmaceuticals market in the Netherlands
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in the Netherlands
Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Netherlands pharmaceuticals market with five year forecasts
Reasons to buy
What was the size of the Netherlands pharmaceuticals market by value in 2017?
What will be the size of the Netherlands pharmaceuticals market in 2022?
What factors are affecting the strength of competition in the Netherlands pharmaceuticals market?
How has the market performed over the last five years?
Who are the top competitiors in the Netherlands's pharmaceuticals market?